These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 21828272)
1. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Zuber J; Rappaport AR; Luo W; Wang E; Chen C; Vaseva AV; Shi J; Weissmueller S; Fellmann C; Taylor MJ; Weissenboeck M; Graeber TG; Kogan SC; Vakoc CR; Lowe SW Genes Dev; 2011 Aug; 25(15):1628-40. PubMed ID: 21828272 [TBL] [Abstract][Full Text] [Related]
2. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes. Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419 [TBL] [Abstract][Full Text] [Related]
3. The mechanism of MYB transcriptional regulation by MLL-AF9 oncoprotein. Cao L; Mitra P; Gonda TJ Sci Rep; 2019 Dec; 9(1):20084. PubMed ID: 31882723 [TBL] [Abstract][Full Text] [Related]
4. miR-150 blocks MLL-AF9-associated leukemia through oncogene repression. Bousquet M; Zhuang G; Meng C; Ying W; Cheruku PS; Shie AT; Wang S; Ge G; Wong P; Wang G; Safe S; Zhou B Mol Cancer Res; 2013 Aug; 11(8):912-22. PubMed ID: 23604034 [TBL] [Abstract][Full Text] [Related]
5. NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemia. Sachs Z; LaRue RS; Nguyen HT; Sachs K; Noble KE; Mohd Hassan NA; Diaz-Flores E; Rathe SK; Sarver AL; Bendall SC; Ha NA; Diers MD; Nolan GP; Shannon KM; Largaespada DA Blood; 2014 Nov; 124(22):3274-83. PubMed ID: 25316678 [TBL] [Abstract][Full Text] [Related]
6. The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia. Armenteros-Monterroso E; Zhao L; Gasparoli L; Brooks T; Pearce K; Mansour MR; Martens JHA; de Boer J; Williams O Leukemia; 2019 Dec; 33(12):2817-2829. PubMed ID: 31138842 [TBL] [Abstract][Full Text] [Related]
7. c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis. Jin S; Zhao H; Yi Y; Nakata Y; Kalota A; Gewirtz AM J Clin Invest; 2010 Feb; 120(2):593-606. PubMed ID: 20093773 [TBL] [Abstract][Full Text] [Related]
8. Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias. Shetzline SE; Rallapalli R; Dowd KJ; Zou S; Nakata Y; Swider CR; Kalota A; Choi JK; Gewirtz AM Blood; 2004 Sep; 104(6):1833-40. PubMed ID: 15187020 [TBL] [Abstract][Full Text] [Related]
9. Targeting acute myeloid leukemia by drug-induced c-MYB degradation. Walf-Vorderwülbecke V; Pearce K; Brooks T; Hubank M; van den Heuvel-Eibrink MM; Zwaan CM; Adams S; Edwards D; Bartram J; Samarasinghe S; Ancliff P; Khwaja A; Goulden N; Williams G; de Boer J; Williams O Leukemia; 2018 Apr; 32(4):882-889. PubMed ID: 29089643 [TBL] [Abstract][Full Text] [Related]